Volume 28, Number 2 (2002), in the article “Low-Dose N-Butyldeoxynojirimycin (OGT 918) for Type I Gaucher Disease,” by Rene Heitner, Deborah Elstein, Johannes Aerts, Sonja van Weely, and Ari Zimran, pages 127–133 (doi:10.1006/bcmd.2002.0497)

Author:  

Publisher: Academic Press

ISSN: 1079-9796

Source: Blood Cells, Molecules, and Diseases, Vol.28, Iss.2, 2002-02, pp. : 301-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content